IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)

Victor Berg; DO Haskard; A Fedorowski; A Hartley; Isabella Kardys; M Caga-Anan; Martijn Akkerhuis; Rohit Oemrawsingh; Robert Jan van Geuns; Peter de Jaegere; Nicolas van Mieghem; Evelyn Regar; Jurgen Ligthart; V Umans; PWJC Serruys; O Melander; Eric Boersma; RY Khamis

doi:10.1016/j.ebiom.2018.08.023

IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)

Victor Berg, DO Haskard, A Fedorowski, A Hartley, Isabella Kardys, M Caga-Anan, Martijn Akkerhuis, Rohit Oemrawsingh, Robert Jan van Geuns, Peter de Jaegere, Nicolas van Mieghem, Evelyn Regar, Jurgen Ligthart, V Umans, PWJC Serruys, O Melander, Eric Boersma, RY Khamis

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

7 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	63-72
Number of pages	10
Journal	EBioMedicine
Volume	36
DOIs	https://doi.org/10.1016/j.ebiom.2018.08.023
Publication status	Published - 2018

Research programs

EMC COEUR-09

Access to Document

10.1016/j.ebiom.2018.08.023

REPUB_109857-OA.pdfFinal published version, 66.2 KB

http://hdl.handle.net/1765/109857

Cite this

Berg, V., Haskard, DO., Fedorowski, A., Hartley, A., Kardys, I., Caga-Anan, M., Akkerhuis, M., Oemrawsingh, R., van Geuns, R. J., de Jaegere, P., van Mieghem, N., Regar, E., Ligthart, J., Umans, V., Serruys, PWJC., Melander, O., Boersma, E., & Khamis, RY. (2018). IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3). EBioMedicine, 36, 63-72. https://doi.org/10.1016/j.ebiom.2018.08.023

@article{ee2b0ee8e1dd4fc6a41988c224e20b4a,

title = "IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)",

author = "Victor Berg and DO Haskard and A Fedorowski and A Hartley and Isabella Kardys and M Caga-Anan and Martijn Akkerhuis and Rohit Oemrawsingh and {van Geuns}, {Robert Jan} and {de Jaegere}, Peter and {van Mieghem}, Nicolas and Evelyn Regar and Jurgen Ligthart and V Umans and PWJC Serruys and O Melander and Eric Boersma and RY Khamis",

year = "2018",

doi = "10.1016/j.ebiom.2018.08.023",

language = "Undefined/Unknown",

volume = "36",

pages = "63--72",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier",

}

Berg, V, Haskard, DO, Fedorowski, A, Hartley, A, Kardys, I, Caga-Anan, M, Akkerhuis, M, Oemrawsingh, R, van Geuns, RJ, de Jaegere, P , van Mieghem, N, Regar, E, Ligthart, J, Umans, V, Serruys, PWJC, Melander, O, Boersma, E & Khamis, RY 2018, 'IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)', EBioMedicine, vol. 36, pp. 63-72. https://doi.org/10.1016/j.ebiom.2018.08.023

IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3). / Berg, Victor; Haskard, DO; Fedorowski, A et al.
In: EBioMedicine, Vol. 36, 2018, p. 63-72.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)

AU - Berg, Victor

AU - Haskard, DO

AU - Fedorowski, A

AU - Hartley, A

AU - Kardys, Isabella

AU - Caga-Anan, M

AU - Akkerhuis, Martijn

AU - Oemrawsingh, Rohit

AU - van Geuns, Robert Jan

AU - de Jaegere, Peter

AU - van Mieghem, Nicolas

AU - Regar, Evelyn

AU - Ligthart, Jurgen

AU - Umans, V

AU - Serruys, PWJC

AU - Melander, O

AU - Boersma, Eric

AU - Khamis, RY

PY - 2018

Y1 - 2018

U2 - 10.1016/j.ebiom.2018.08.023

DO - 10.1016/j.ebiom.2018.08.023

M3 - Article

C2 - 30131305

SN - 2352-3964

VL - 36

SP - 63

EP - 72

JO - EBioMedicine

JF - EBioMedicine

ER -